Angels Escorsell
Overview
Explore the profile of Angels Escorsell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laghi L, Ortiz M, Rossi G, Roman E, Mengucci C, Canto E, et al.
Biomolecules
. 2024 Nov;
14(11).
PMID: 39595586
Frailty in cirrhosis or advanced chronic liver disease (ACLD) is a relevant prognostic factor. In the present study, we aimed to analyze potential biomarkers associated with frailty and its improvement...
2.
Alvarado-Tapias E, Brujats A, Puente A, Ardevol A, Rodriguez-Arias A, Fajardo J, et al.
Hepatology
. 2024 Nov;
PMID: 39509369
Background And Aims: Carvedilol is a nonselective β-blocker (NSBB) with anti-α1-adrenergic activity, more effective than traditional NSBBs in reducing portal pressure hepatic venous pressure gradient (HVPG). However, 35%-45% of patients...
3.
Brujats A, Huerta A, Osuna-Gomez R, Guinart-Cuadra A, Ferrero-Gregori A, Pujol C, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125872
Advanced chronic liver disease (ACLD) is associated with a wide spectrum of immune dysfunction. The clinical impact of SARS-CoV-2 on the development of decompensation and immune response in unvaccinated outpatients...
4.
Roman E, Kaur N, Sanchez E, Poca M, Padros J, Nadal M, et al.
Hepatol Commun
. 2024 May;
8(5).
PMID: 38701490
Background: Frailty is a predictive factor of hospitalization, falls, and mortality in patients with cirrhosis, regardless of the degree of liver failure. The aim was to analyze whether a multifactorial...
5.
Garcia-Guix M, Ardevol A, Sapena V, Alvarado-Tapias E, Huertas A, Brujats A, et al.
Liver Int
. 2024 Apr;
44(8):1971-1989.
PMID: 38634685
Background And Aims: Decompensated-cirrhosis encompasses several stages with different prognosis, such as bleeding, ascites and bleeding-plus-ascites. Development of further-decompensation worsens survival, while non-selective β-blockers (NSBBs) can modify the risk. However,...
6.
Cuyas B, Huerta A, Poca M, Alvarado-Tapias E, Brujats A, Roman E, et al.
Sci Rep
. 2024 Feb;
14(1):2718.
PMID: 38302563
Infections are a major cause of morbidity and mortality in cirrhosis, especially those caused by multi-drug resistant bacteria. During the COVID-19 pandemic, the incidence and type of infection in these...
7.
Escorsell A, Garcia-Pagan J, Alvarado-Tapia E, Aracil C, Masnou H, Villanueva C, et al.
JHEP Rep
. 2023 Jun;
5(6):100717.
PMID: 37284139
Background & Aims: Bleeding from gastric fundal varices (isolated gastric varices type 1/gastroesophageal varices type 2) represents a major problem because of a high incidence of rebleeding and death with...
8.
Laghi L, Roman E, Lan Q, Nieto J, Canalda-Baltrons A, Poca M, et al.
Hepatol Commun
. 2023 Apr;
7(4).
PMID: 37026745
To explore the potential mechanisms underlying the effects of a probiotic in cirrhotic patients, we analyzed the blood metabolome using proton nuclear magnetic resonance (1H-NMR) spectroscopy in 32 patients with...
9.
Roman E, Poca M, Amoros-Figueras G, Rosell-Ferrer J, Gely C, Nieto J, et al.
Sci Rep
. 2021 Oct;
11(1):20415.
PMID: 34650096
The phase angle is a versatile measurement to assess body composition, frailty and prognosis in patients with chronic diseases. In cirrhosis, patients often present alterations in body composition that are...
10.
Rodrigues S, Cardenas A, Escorsell A, Bosch J
Semin Liver Dis
. 2019 Mar;
39(2):178-194.
PMID: 30912098
Failure to control variceal bleeding with current recommendations occurs in 10 to 20% of cases. This systematic review and meta-analysis analyzes the experience, results, and complications of "bridge" therapies for...